Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | October 20, 2023 01:31pm

Gainers

  • Aravive (NASDAQ:ARAV) shares rose 67.5% to $0.24 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 90.0 million shares, making up 979.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.3 million.
  • Lipella Pharmaceuticals (NASDAQ:LIPO) stock moved upwards by 42.27% to $2.29. Lipella Pharmaceuticals's stock is trading at a volume of 39.3 million shares as of 13:30 EST. This is 574673.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.2 million.
  • Sagimet Biosciences (NASDAQ:SGMT) shares rose 25.27% to $5.72. As of 13:30 EST, this security is trading at a volume of 70.1K shares, making up 54.7% of its average full-day volume over the last 100 days. The company's market cap stands at $130.9 million.
  • Catalyst Biosciences (NASDAQ:CBIO) shares increased by 23.16% to $0.49. Catalyst Biosciences's stock is trading at a volume of 2.6 million shares as of 13:30 EST. This is 717.8% of its average full-day volume over the last 100 days. The company's market cap stands at $18.7 million.
  • Redhill Biopharma (NASDAQ:RDHL) shares rose 20.78% to $0.53. Trading volume for Redhill Biopharma's stock is 1.3 million as of 13:30 EST. This is 89.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 million.
  • Eiger BioPharmaceuticals (NASDAQ:EIGR) stock rose 17.38% to $0.32. The current volume of 117.0K shares is 39.3% of Eiger BioPharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $14.1 million.

Losers

  • Processa Pharma (NASDAQ:PCSA) stock fell 32.4% to $0.36 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 2.8 million shares, making up 157.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.9 million.
  • Atreca (NASDAQ:BCEL) stock declined by 25.7% to $0.27. Atreca's stock is trading at a volume of 2.3 million shares as of 13:30 EST. This is 140.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.7 million.
  • RVL Pharmaceuticals (NASDAQ:RVLP) shares declined by 25.55% to $0.03. Trading volume for RVL Pharmaceuticals's stock is 38.3 million as of 13:30 EST. This is 180.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.4 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock declined by 22.35% to $2.19. The market value of their outstanding shares is at $2.6 million.
  • Renovaro Biosciences (NASDAQ:RENB) stock decreased by 20.87% to $2.73. Renovaro Biosciences's stock is trading at a volume of 397.0K shares as of 13:30 EST. This is 38.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $179.3 million.
  • Outlook Therapeutics (NASDAQ:OTLK) shares decreased by 20.0% to $0.53. As of 13:30 EST, Outlook Therapeutics's stock is trading at a volume of 18.1 million, which is 213.9% of its average full-day volume over the last 100 days. The company's market cap stands at $137.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADIL ARAV BCEL CBIO EIGR LIPO OTLK PCSA RDHL RENB RVLP SGMT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist